Ongoing Research And Development Activities Have Led To Rapid Adoption Of Aptamers As Drug/Drug-Carriers And Is Opening New Growth Avenues

High Demand From Food And Beverage Industry Is Expected To Offer Lucrative Opportunities For Key Manufacturers During Forecast Period.

High Demand From Food And Beverage Industry Is Expected To Offer Lucrative Opportunities For Key Manufacturers During Forecast Period.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global aptamers market is expected to grow at an impressive CAGR of 21% during the forecast period (2020-2025).

Advent of the chemical modification process to increase the nuclease resistance of aptamers, and, in turn, enhance their therapeutic properties creates opportunities galore for players in the aptamer market. This has also lead to steady increase in the demand for aptamers and related products from research institutions.

Rapid advancements in selection technique remain a growth driver for the aptamers market. Significant investments by key manufacturers are expected to boost the growth of the market. Moreover, continuous progress in the research and development of diagnostic equipment and therapeutics undertaken by research institutes is expected to fuel the growth.

For more insights into the Market, Request Brochure of this Report

https://www.factmr.com/connectus/sample?flag=B&rep_id=173

In addition to this, there has been a surge in awareness regarding heath issues, which is boosting the demand for effective diagnostic tools. Moreover, this is expected to offer opportunities for the aptamer market in Europe and other deveoped regions such as North America.

Moreover, surge in knowledge sharing of pharmaceutical know-hows and technologies among established players is projected to boost the expansion of aptamer market during forecast period. Also, emergence of chemical modification process to boost the nuclease resistance of aptamers, and in turn, growth in therapeutic properties creates opportunities for players in the aptamer market. Also, it is expected that aptamers will meet an expanded scope in the food and beverage industry as biosensors.

Besides this, ongoing research and development activities have led to high adoption of aptamers, both, as drugs and drug-carriers. Moreover, their application as diagnostic tools is opening new profitable opportunities for manufacturers. Also, key players in the market are investing in development process to offset any challenges. For instance, Somalogic, Inc. introduced SOMAmer, a next generation selection platform to extract high quality aptamers for diverse applications.

Key Takeaways:

  • High growth expansion is expected in Asia pacific market due to growth in knowledge sharing of technologies and pharmaceutical know-hows among prominent and local players.
  • Methods such as Magnetic-assisted Rapid Aptamer Selection (MARAS) are anticipated to witness rapid adoption, owing to their simplified enzymatic steps, which amplifies the selection process.
  • North America is expected to lead the market by the early bird’s advantage of advanced technologies that key players are taking advantage of in the region.

Growth Drivers:

  • Growth of the market in Asia Pacific is driven by collaborative efforts taken by key players in developed regions to enter into untapped market.
  • Surge in awareness regarding health issues is witnessed in various developed economies, which is boosting the demand for effective diagnostic tools. This is expected to create opportunities for the aptamer market.
  • Continuous progress in the research and development of therapeutics and diagnostics equipment by research institutes is projected to demand an ongoing supply of aptamers.

For Comprehensive Insights Ask An Analyst Here

https://www.factmr.com/connectus/sample?flag=AE&rep_id=173

Restraints:

  • Aptamers lack a standard regulatory process for quality and safety. However, the approval process remains stringent in developed regions such as Europe and North America. On the backdrop of lack of universal regulatory norms, the penetration of aptamers is very limited in these regions.
  • Moreover, in regions such as Europe, there is a tedious documentation involved for starting clinical trials for aptamers.
  • In regions such as Asia Pacific and Middle East & Africa, there is a low level of awareness regarding aptamers.
  • Also, aptamers are relatively novel technology and some of its qualities are still unexplored. These factors act as a restraint to the growth of the market.
  • Aptamers are expected to have a short life (minutes to hours), which acts as a restraint to practical application of aptamers in the development of therapeutics.

Aptamer Market – Assessment of Key Segments

By Application:

  • Research
  • Diagnostics
  • Therapeutics
  • Others

By Selection Technique:

  • SELEX Technique
  • Others

By Material:

  • Nucleic Acid Aptamers
  • Peptide Aptamers

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Rest of World

Get Customization on this Report for Specific Research Solutions

https://www.factmr.com/connectus/sample?flag=RC&rep_id=173

Explore Fact.MR’s Coverage on the Healthcare Domain

Prostate Cancer Diagnostics Market - An increasing geriatric population across the developed world along with access to top-quality healthcare is expected to benefit the prostate cancer diagnostics market. Healthcare spending is growing by leaps and bounds both through the government as well as private providers.

Syringes Market - Supporting this notion, syringes continue to be a key product in the healthcare industry, offering optimum drug administration with minimal discomfort. The market is projected to expand 2.6x, surpassing a revenue of approximately US$ 37 Billion by 2031.

Urodynamic Devices Market - These incidences have propelled demand for urodynamic devices, owing to rising clinical urgency. A number of healthcare initiatives are being taken for creating awareness about urological problems, along with the availability of treatment and diagnostics for urological disorders.

Recombinant Protein Market - Recombinant protein is highly effective, and plays an indispensable role in treatment of certain diseases, such as hemophilia (excluding blood coagulation factor that has an extremely limited source).

Gas Chromatography Market - Gas chromatography has been combined with mass spectrometry, denoted as GC-MS, for applications in detection of drugs, explosives investigation, environmental analysis, identifying unknown samples, and fire investigation.

Antibodies Market - The global demand for antibodies is expected to remain moderate in the forthcoming years. Increasing prevalence of chronic ailments such as autoimmune diseases, cancer, diabetes and others is encouraging manufacturers to step up investments in R&D activities pertaining to antibodies.

Amniocentesis Needle Market - Demand for the amniocentesis needles is expected to gain momentum attributed to growing need for removing excessive amniotic fluid from around the baby. Excessive amniotic fluid during pregnancy leads to increasing risks of complication.

Prefilled Syringes Market - Advancements in packaging technology across the healthcare and pharmaceutical sector have paved the way for prefilled syringes. As stakeholders look to attain efficiency with regards to drug delivery and distribution, regulatory authorities are approving numerous syringe designs, albeit post consideration of safety of administration.

Actigraphy Sensors & PSG Devices Market - As actigraphy sensor and PSG devices make it simpler for users to monitor their sleep duration with more convenience and accuracy, it helps in diagnosing sleep diseases reliably and makes treatments more effective.

Lithotripsy Devices Market - Lithotripsy is a popular procedure for treating kidney stones, owing to its relative safety, low cost, shorter recovery time, and favourable patient results. As a result, all of these variables are responsible for the market’s expansion. From 2021 to 2031, sales are expected to grow at around 5% CAGR.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000’s trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Follow Us: LinkedIn | Twitter